[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100632253":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":15,"centralContacts":21,"locations":30,"responsibleParty":46,"collaborators":10,"id":48,"slug":49,"hasResults":50,"nctId":51,"briefTitle":52,"officialTitle":52,"acronym":10,"eligibilityCriteria":53,"healthyVolunteers":54,"sex":55,"minAge":56,"maxAge":10,"enrollmentInfo":57,"targetDuration":10,"studyType":60,"phases":10,"briefSummary":61,"conditions":62,"keywords":68,"overallStatus":32,"whyStopped":10,"lastUpdateSubmitDate":70,"lastUpdatePostDateStruct":71,"startDateStruct":74,"completionDateStruct":76,"leadSponsor":78,"locationsCount":79},{"fullName":5,"class":6},"Odense University Hospital","OTHER",[8,11,13],{"label":9,"type":10,"description":10,"interventionNames":10},"Patients with chronic kidney disease diagnosed or suspected for calciphylaxis",null,{"label":12,"type":10,"description":10,"interventionNames":10},"Matched control patients with chronic kidney disease without calciphylaxis",{"label":14,"type":10,"description":10,"interventionNames":10},"Age matched healthy reference group",[16,19],{"name":17,"affiliation":5,"role":18},"Subagini Nagarajah, PhD","PRINCIPAL_INVESTIGATOR",{"name":20,"affiliation":5,"role":18},"Alexandra Scholze, Dr.med, PhD",[22,26],{"name":17,"role":23,"phone":24,"phoneExt":10,"email":25},"CONTACT","+45 40498337","subagini.nagarajah3@rsyd.dk",{"name":27,"role":23,"phone":28,"phoneExt":10,"email":29},"Alexandra Scholze, Dr. med., PhD","+45 65412402","Alexandra.Scholze@rsyd.dk",[31],{"facility":5,"status":32,"city":33,"state":10,"zip":34,"country":35,"countryCode":36,"cosmosGeoPoint":37,"geoPoint":42,"contacts":43},"RECRUITING","Odense","5000","Denmark","DK",{"type":38,"coordinates":39},"Point",[40,41],10.38831,55.39594,{"lat":41,"lon":40},[44,45],{"name":17,"role":23,"phone":24,"phoneExt":10,"email":25},{"name":20,"role":23,"phone":28,"phoneExt":10,"email":29},{"type":47,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100632253","calciphylaxis-in-patients-with-chronic-kidney-disease---a-study-of-the-danish-calciphylaxis-research-initiative-dancari-100632253",false,"NCT07511283","Calciphylaxis in Patients With Chronic Kidney Disease - A Study of the Danish Calciphylaxis Research Initiative (DanCaRI)","Inclusion Criteria:\n\nCases\n\n* Age ≥18 years.\n* CKD.\n* Suspicion of calciphylaxis or newly diagnosed calciphylaxis episode. The suspicion or diagnosis of calciphylaxis is a mutual decision of the involved medical specialties (nephrologist, dermatologist, pathologist, other).\n* Ability to give informed consent.\n* Ability to participate in a clinical study as assessed by the local investigator.\n* Provides written informed consent.\n\nControls\n\n* Age ≥18 years.\n* CKD\n* Ability to give informed consent.\n* Ability to participate in a clinical study as assessed by the local investigator.\n* Provides written informed consent.\n\nHealthy reference group\n\n* Age ≥18 years.\n* Self-assessed as healthy, confirmed by local investigators at inclusion\n\nExclusion Criteria:\n\nCases\n\n\\- the calciphylaxis diagnosis becomes excluded\n\nControls - Being diagnosed with calciphylaxis\n\nHealthy controls Up to 60 years of age: eGFR below 60 ml\u002Fmin\u002F1.72m2.\n\n\\- Over 60 years of age: eGFR below the 95% confidence interval for eGFR adjusted for age (Danish Society of Nephrology references ranges)",true,"ALL","18 Years",{"count":58,"type":59},860,"ESTIMATED","OBSERVATIONAL","Calciphylaxis is a rare yet life-threatening condition involving pronounced calcification in small blood vessels of the skin.\n\nKnowledge about its underlying mechanisms and contributing risk factors remains limited. Chronic kidney disease is one of the strongest disease predictors. No evidence based effective therapy is currently available. Research on the topic is mainly hindered by the condition's rarity.\n\nThe study Calciphylaxis in patients with chronic kidney disease - A study of the Danish Calciphylaxis Research Initiative (DanCaRI) is set up to facilitate the systematic retrospective and prospective comparison of patients with chronic kidney disease and calciphylaxis to matched patients with chronic kidney disease who did not develop calciphylaxis thereby providing new knowledge that can support prevention, early detection, and new treatment approaches.",[63,64,65,66,67],"Calciphylaxis","Calcific Uremic Arteriolopathy","End Stage Renal Disease (ESRD)","Chronic Kidney Diseases","Nephrogenic Calciphylaxis",[63,64,67,69,66],"End Stage Renal Disease","2026-03-30",{"date":72,"type":73},"2026-04-06","ACTUAL",{"date":75,"type":59},"2026-04",{"date":77,"type":59},"2040-06",{"name":5,"class":6},1]